Search Results - "Dorfman, Liza"

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer by Kraya, Adam A, Maxwell, Kara N, Wubbenhorst, Bradley, Wenz, Brandon M, Pluta, John, Rech, Andrew J, Dorfman, Liza M, Lunceford, Nicole, Barrett, Amanda, Mitra, Nandita, Morrissette, Jennifer J D, Feldman, Michael, Nayak, Anupma, Domchek, Susan M, Vonderheide, Robert H, Nathanson, Katherine L

“…Breast cancers with alterations have a relatively high mutational load, suggesting that immune checkpoint blockade may be a potential treatment option…”
Get full text

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma by Huang, Alexander C., Orlowski, Robert J., Xu, Xiaowei, Mick, Rosemarie, George, Sangeeth M., Yan, Patrick K., Manne, Sasikanth, Kraya, Adam A., Wubbenhorst, Bradley, Dorfman, Liza, D’Andrea, Kurt, Wenz, Brandon M., Liu, Shujing, Chilukuri, Lakshmi, Kozlov, Andrew, Carberry, Mary, Giles, Lydia, Kier, Melanie W., Quagliarello, Felix, McGettigan, Suzanne, Kreider, Kristin, Annamalai, Lakshmanan, Zhao, Qing, Mogg, Robin, Xu, Wei, Blumenschein, Wendy M., Yearley, Jennifer H., Linette, Gerald P., Amaravadi, Ravi K., Schuchter, Lynn M., Herati, Ramin S., Bengsch, Bertram, Nathanson, Katherine L., Farwell, Michael D., Karakousis, Giorgos C., Wherry, E. John, Mitchell, Tara C.

“…Immunologic responses to anti-PD-1 therapy in melanoma patients occur rapidly with pharmacodynamic T cell responses detectable in blood by 3 weeks. It is…”
Get full text

Abstract 1682: Non-V600 BRAF mutants in melanoma: Multiple MAPK mutations and distinctive RNA expression by Kiernan, Elizabeth, Bastian, Paul, Dorfman, Liza, Anastopoulos, Ioannis N., Wubbenhorst, Brad, Krepler, Clemens, Rebecca, Vito, Herlyn, Meenhard, Nathanson, Katherine

“…Abstract Large discovery sequencing analyses conducted by our group and others enabled classification of melanomas into major and minor subtypes, helping to…”
Get full text